Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer’s Disease

    The incidence of Alzheimer’s disease (AD) increases significantly following chronic stress and brain ischemia which, over the years, cause accumulation of toxic amyloid species and brain damage. The effects of...

    Eva Babusikova, Dusan Dobrota, Anthony J. Turner in Biochemistry (Moscow) (2021)

  2. Article

    Molecular Mechanisms of Cognitive Impairment and Intellectual Disability—Virtual ESN Mini-Conference in Conjunction with the FENS Forum, July 11–15, 2020

    Illana Gozes, Natalia N. Nalivaeva in Journal of Molecular Neuroscience (2020)

  3. No Access

    Article

    New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes

    Currently, deficit of amyloid β-peptide (Aβ) clearance from the brain is considered as one of the possible causes of amyloid accumulation and neuronal death in the sporadic form of Alzheimer’s disease (AD). Aβ...

    Natalia N. Nalivaeva, Nikolai D. Belyaev, Anthony J. Turner in Neurochemical Research (2016)

  4. No Access

    Article

    Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues

    Due to an increasing life expectancy in develo** countries, cases of type 2 diabetes and Alzheimer’s disease (AD) in the elderly are growing exponentially. Despite a causative link between diabetes and AD, g...

    Ekaterina G. Kochkina, Svetlana A. Plesneva, Dmitrii S. Vasilev in Biogerontology (2015)

  5. Article

    Regulation of distinct pools of amyloid β-protein by multiple cellular proteases

    Alzheimer’s disease (AD) is a progressive, age-related neurodegenerative disorder characterized by extracellular and intracellular deposition of the amyloid β-protein (Aβ). The study of rare, familial forms of...

    Malcolm A Leissring, Anthony J Turner in Alzheimer's Research & Therapy (2013)

  6. No Access

    Article

    Effect of Sodium Valproate Administration on Brain Neprilysin Expression and Memory in Rats

    Alzheimer's disease (AD) is accompanied by memory loss due to neuronal cell death caused by toxic amyloid β-peptide (Aβ) aggregates. In the healthy brain, a group of amyloid-degrading enzymes including neprily...

    Natalia N. Nalivaeva, Nikolai D. Belyaev in Journal of Molecular Neuroscience (2012)

  7. Chapter

    Metalloproteases and Proteolytic Processing

    Proteolytic enzymes constitute around 2% of the human genome and are involved in all stages of cell and organism development from fertilization through to cell death. In the human genome the major classes of p...

    Anthony J. Turner, Natalia N. Nalivaeva in Post-Translational Modifications in Health… (2011)

  8. Article

    Not just angiotensinases: new roles for the angiotensin-converting enzymes

    The renin-angiotensin system (RAS) is a critical regulator of blood pressure and fluid homeostasis. Angiotensin II, the primary bioactive peptide of the RAS, is generated from angiotensin I by angiotensin-conv...

    Daniel W. Lambert, Nicola E. Clarke in Cellular and Molecular Life Sciences (2010)

  9. Article

    Open Access

    Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships

    The neprilysin (M13) family of endopeptidases are zinc-metalloenzymes, the majority of which are type II integral membrane proteins. The best characterised of this family is neprilysin, which has important rol...

    Nicholas D Bland, John W Pinney, Josie E Thomas in BMC Evolutionary Biology (2008)

  10. No Access

    Article

    Effects of Hypoxia and Oxidative Stress on Expression of Neprilysin in Human Neuroblastoma Cells and Rat Cortical Neurones and Astrocytes

    Pathogenesis of Alzheimer’s disease (AD), which is characterised by accumulation of extracellular deposits of β-amyloid peptide (Aβ) in the brain, has recently been linked to vascular disorders such as ischemi...

    Lilia Fisk, Natalia N. Nalivaeva, John P. Boyle in Neurochemical Research (2007)

  11. Article

    Open Access

    Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE

    Mammalian angiotensin converting enzyme (ACE) plays a key role in blood pressure regulation. Although multiple ACE-like proteins exist in non-mammalian organisms, to date only one other ACE homologue, ACE2, ha...

    Monika Rella, Joann L Elliot, Timothy J Revett, Jerry Lanfear, Anne Phelan in BMC Genomics (2007)

  12. No Access

    Article

    Angiotensin-converting enzyme as a GPIase: a critical reevaluation

    Lilia Leisle, Edward T Parkin, Anthony J Turner, Nigel M. Hooper in Nature Medicine (2005)

  13. No Access

    Article

    Effects of prenatal hypoxia on expression of amyloid precursor protein and metallopeptidases in the rat brain

    In the present study we have investigated the effect of prenatal hypoxia on expression of amyloid precursor protein (APP) and some metallopeptidases, which regulate β-amyloid peptide (Aβ) levels (neprilysin (NEP)...

    Natalia N. Nalivaeva, Lilia Fisk, Rosa M. Canet. Aviles in Letters in Peptide Science (2003)

  14. Article

    Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function

    Angiotensin converting enzyme-2 (ACE2) is a recently described homologue of the vasoactive peptidase, angiotensin converting enzyme (ACE). Like ACE, ACE2 is an integral (type I) membrane zinc metallopeptidase,...

    Fiona J. Warner, Jodie L. Guy, Dan W. Lambert in Letters in Peptide Science (2003)

  15. No Access

    Article

    An ACE structure

    The structure of one of the two catalytic domains of angiotensin converting enzyme in complex with an inhibitor provides molecular insights into the substrate- and inhibitor-binding profiles of this clinically...

    Nigel M. Hooper, Anthony J. Turner in Nature Structural & Molecular Biology (2003)

  16. No Access

    Protocol

    Detection and Assessment of Endothelin-Converting Enzyme Activity

    The biologically active vasoconstrictor peptide endothelin (ET-1) is produced from its inactive precursor big endothelin (big ET-1) in a process catalyzed by an endothelin-converting enzyme (ECE). Two potentia...

    Carolyn D. Jackson, Anthony J. Turner in Peptide Research Protocols (2002)

  17. No Access

    Chapter

    The Neprilysin Family in Health and Disease

    The mammalian neprilysin (NEP) family comprises at least seven members: NEP itself, Kell blood group antigen (KELL), the endothelin-converting enzymes (ECE-1 and ECE-2), the enzyme PEX, associated with X-linke...

    Anthony J. Turner, Carolyn D. Brown in Cellular Peptidases in Immune Functions an… (2002)

  18. No Access

    Chapter

    The Role of Proteolysis in Alzheimer’s Disease

    Alzheimer’s disease is characterised by the progressive deposition of the 4 kDa β-amyloid peptide (Aβ) in extracellular senile plaques in the brain, Aβ is derived by proteolytic cleavage of the amyloid precurs...

    Nigel M. Hooper, Alison J. Trew in Cellular Peptidases in Immune Functions an… (2002)

  19. No Access

    Protocol

    Distribution of Presenilins and Amyloid Precursor Protein (APP) in Detergent-Insoluble Membrane Domains

    Until recently, the detergent insolubility of certain membrane-associated proteins was singularly attributed to an association with the cytoskeleton. However, in 1988 we observed that a number of glycosyl-phos...

    Edward T. Parkin, Anthony J. Turner, Nigel M. Hooper in Alzheimer's Disease (2000)

  20. No Access

    Protocol

    Inhibition of α-Secretase by Zinc Metalloproteinase Inhibitors

    The amyloid precursor protein (APP) is cleaved by at least three proteinases termed the α-, β-, and γ-secretases. Cleavage of APP at the N-terminus of the β-amyloid (Aβ) peptide by β-secretase and at the C-ter...

    S. Parvathy, Anthony J. Turner, Nigel M. Hooper in Alzheimer's Disease (2000)

previous disabled Page of 2